Moscow, Russia--(Newsfile Corp. - August 16, 2023) - Polypeptide.ltd, a frontrunner in delivering exceptional peptide services, proudly announces a substantial expansion of its production capacity.

1 This media release and key figures table include references to operational indicators and alternative financial performance measures (APM) that are not defined or specified by IFRS. These APM should ...

The base complementarity of DNA can now be used to rationally design artificial nanostructures that can adopt versatile two- and three-dimensional shapes, such as different polyhedra 1,2,3,4. In ...

Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all proposals put ...

The collaboration between Donaldson and PolyPeptide marks a milestone in the pharmaceutical industry's pursuit of environmentally friendly manufacturing practices. By leveraging Donaldson's experience ...

Significant control over PolyPeptide Group by private companies implies that the general public has more power to influence management and governance-related decisions 56% of the company is held by a ...

Lonza, which bought a Belgian plant a decade ago to increase its peptide capacity, has now decided to let it and its 280 employees go. The contract manufacturer is selling the operation to peptide ...